IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular Neurodegeneration

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

13.63

h-Index

2022-2023

 103

Rank

2022-2023

 253

SJR

2022-2023

 5.158

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular Neurodegeneration
Abbreviation Mol. Neurodegener.
Publication Type Journal
Subject Area, Categories, Scope Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1)
h-index 103
Overall Rank/Ranking 253
SCImago Journal Rank (SJR) 5.158
Impact Score 13.63
Publisher BioMed Central Ltd.
Country United Kingdom
ISSN 17501326
Best Quartile Q1
Coverage History 2006-2022




Aim and Scope


Molecular Neurodegeneration is an open access, peer-reviewed online journal that will encompass all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer"s disease, Parkinson disease, Huntington disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger.


About Molecular Neurodegeneration


Molecular Neurodegeneration is a journal covering the technologies/fields/categories related to Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1). It is published by BioMed Central Ltd.. The overall rank of Molecular Neurodegeneration is 253. According to SCImago Journal Rank (SJR), this journal is ranked 5.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 103. The best quartile for this journal is Q1.

The ISSN of Molecular Neurodegeneration journal is 17501326. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Neurodegeneration is cited by a total of 3203 articles during the last 3 years (Preceding 2022).


Molecular Neurodegeneration Impact IF 2022-2023


The Impact IF 2022 of Molecular Neurodegeneration is 13.63, which is computed in 2023 as per its definition. Molecular Neurodegeneration IF is decreased by a factor of 3.13 and approximate percentage change is -18.68% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular Neurodegeneration Impact IF 2023 Prediction


Impact IF 2022 of Molecular Neurodegeneration is 13.63. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Molecular Neurodegeneration. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 13.63
2021 16.76
2020 12.10
2019 9.31
2018 8.21
2017 6.78
2016 7.32
2015 6.85
2014 7.01

Molecular Neurodegeneration h-index


  Table Setting

Molecular Neurodegeneration has an h-index of 103. It means 103 articles of this journal have more than 103 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular Neurodegeneration ISSN


The ISSN of Molecular Neurodegeneration is 17501326. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular Neurodegeneration Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular Neurodegeneration is 253. According to SCImago Journal Rank (SJR), this journal is ranked 5.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular Neurodegeneration by Year


Year SJR
2023/2024 Coming Soon
2022 5.158
2021 4.731
2020 5.565
2019 4.040
2018 3.988
2017 3.418
2016 3.684
2015 3.636
2014 3.315

Ranking of Molecular Neurodegeneration by Year


Year Ranking
2023/2024 Coming Soon
2022 253
2021 295
2020 240
2019 376
2018 409
2017 514
2016 463
2015 455
2014 550

Molecular Neurodegeneration Publisher


Table Setting

Molecular Neurodegeneration is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular Neurodegeneration is Mol. Neurodegener.. This abbreviation ('Mol. Neurodegener.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular Neurodegeneration


If your research field is/are related to Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular Neurodegeneration?

Molecular Neurodegeneration latest impact IF is 13.63. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 16.76 (2021) and 6.78 (2017), respectively, in the last 9 years. Moreover, its average IS is 9.77 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Molecular Neurodegeneration?

The Molecular Neurodegeneration has an SJR (SCImago Journal Rank) of 5.158, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 5.565 in 2020 and the lowest being 3.315 in 2014. Furthermore, the average SJR of the Molecular Neurodegeneration over the previous 9-year period stands at 9.77.


What's the latest h-index of the Molecular Neurodegeneration?

The latest h-index of the Molecular Neurodegeneration is 103.


Who's the publisher of the Molecular Neurodegeneration?

The Molecular Neurodegeneration is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Molecular Neurodegeneration?

The Molecular Neurodegeneration is currently ranked 253 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 240 in 2020 and its lowest position of 550 in 2014.


What's the abbreviation or short name for the Molecular Neurodegeneration?

The standard ISO4 abbreviation for the Molecular Neurodegeneration is Mol. Neurodegener..


Is the "Molecular Neurodegeneration" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular Neurodegeneration is classified as a journal that the BioMed Central Ltd. publishes.


What's the scope or major areas of the Molecular Neurodegeneration?

The Molecular Neurodegeneration encompasses the following areas:

  • Cellular and Molecular Neuroscience
  • Molecular Biology
  • Neurology (clinical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular Neurodegeneration?

The Molecular Neurodegeneration is assigned the following International Standard Serial Numbers (ISSN): 17501326.


What's the best quartile of the Molecular Neurodegeneration?

The best quartile for the Molecular Neurodegeneration is Q1 (2022).


What's the coverage history of the Molecular Neurodegeneration?

The Molecular Neurodegeneration coverage history can be summarized as follows: 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Supply Chain Management journal 378 Wiley-Blackwell 104 12.58
International Journal of Applied Linguistics journal 7321 Wiley-Blackwell Publishing Ltd 51 2.00
Proceedings of the International Semiconductor Conference, CAS conference and proceedings 25734 Institute of Electrical and Electronics Engineers Inc. 16 0.00
Journal des Professionnels de l'Enfance journal 27577 TPMA 2 0.00
Poljoprivreda journal 20724 Faculty of Agriculture in Osijek 14 0.67
Geo-Info journal 30490 Nederlandse Vereniging voor Kartografie 2 0.00
WSEAS Transactions on Environment and Development journal 17731 World Scientific and Engineering Academy and Society 23 1.33
Brazilian Journal of Physical Therapy journal 4378 Elsevier Editora Ltda 45 3.41
Epites-Epiteszettudomany journal 23580 Akademiai Kiado 4 0.06
International Journal of Environment and Waste Management journal 18983 Inderscience Enterprises Ltd. 22 0.73

Check complete list




Year wise Impact Score (IS) of Molecular Neurodegeneration

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 13.63
2021 16.76
2020 12.10
2019 9.31
2018 8.21
2017 6.78
2016 7.32
2015 6.85
2014 7.01



Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Translational Neurodegeneration
BioMed Central Ltd. | United Kingdom

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Cell Death and Disease
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Cell Host and Microbe
Cell Press | United States

Cell Metabolism
Cell Press | United States

Molecular Cell
Cell Press | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

See All